The CEO of Xoma (NASDAQ: XOMA) is Buying Shares

By Carrie Williams

Yesterday, the CEO of Xoma (XOMAResearch Report), James Neal, bought shares of XOMA for $25.96K.

Following James Neal’s last XOMA Buy transaction on December 21, 2018, the stock climbed by 12.5%. This recent transaction increases James Neal’s holding in the company by 5.28% to a total of $561K.

See today’s analyst top recommended stocks >>

Based on Xoma’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $8.86 million and quarterly net profit of $1.85 million. In comparison, last year the company earned revenue of $1.69 million and had a GAAP net loss of $3.01 million. The company has a one-year high of $28.85 and a one-year low of $11.50. Currently, Xoma has an average volume of 75.00K.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

XOMA Corp. engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.